- Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic2022 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové, Ústřední knihovna
- Andersonova-Fabryho choroba2016 | 1. lékařská fakulta
- Nationwide screening for Fabry disease in unselected stroke patients2021 | 1. lékařská fakulta, 2. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study2023 | 1. lékařská fakulta
- Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study2023 | 1. lékařská fakulta